What is Fruquintinib: Uses, Dosage, Side Effects and More

Fruquintinib is a targeted cancer medication that helps slow tumor growth by blocking blood vessels that feed cancer cells. This oral medication belongs to a class of drugs called kinase inhibitors, which work like molecular switches to turn off signals that help tumors grow and spread.

You might be reading this because your doctor has mentioned fruquintinib as a treatment option, or perhaps you're researching on behalf of someone you care about. Understanding your medication can help you feel more confident about your treatment journey.

What is Fruquintinib?

Fruquintinib is a prescription cancer medication that targets specific proteins involved in tumor growth. It works by blocking VEGFR (vascular endothelial growth factor receptor), which essentially cuts off the blood supply that tumors need to grow larger.

Think of it as closing off the highways that deliver nutrients to cancer cells. Without these pathways, tumors have a much harder time growing and spreading to other parts of your body.

This medication is considered a targeted therapy, meaning it focuses on specific molecular targets rather than affecting all rapidly dividing cells like traditional chemotherapy does.

What is Fruquintinib Used For?

Fruquintinib is primarily used to treat colorectal cancer that has spread to other parts of the body (metastatic colorectal cancer). Your doctor typically prescribes this medication when other treatments haven't worked as well as hoped.

It's specifically approved for patients whose cancer has continued to grow despite previous treatments with other chemotherapy drugs. This makes fruquintinib what doctors call a "third-line" or later treatment option.

Your healthcare team will determine if fruquintinib is right for you based on your specific cancer type, previous treatments, and overall health condition.

How Does Fruquintinib Work?

Fruquintinib works by blocking multiple protein pathways that cancer cells use to grow and create new blood vessels. It's considered a moderately strong targeted therapy that specifically interrupts the signals tumors need to thrive.

The medication targets three main receptors: VEGFR1, VEGFR2, and VEGFR3. These receptors are like cellular communication channels that tell blood vessels to grow toward tumors, providing them with oxygen and nutrients.

By blocking these signals, fruquintinib helps slow tumor growth and may shrink existing tumors. It also makes it harder for cancer cells to spread to new areas of your body.

How Should I Take Fruquintinib?

Take fruquintinib exactly as your doctor prescribes, typically once daily with food. Taking it with a meal helps your body absorb the medication more effectively and can reduce stomach upset.

Swallow the capsules whole with a full glass of water. Don't crush, chew, or open the capsules, as this can affect how the medication works in your body.

Try to take your dose at the same time each day to help you remember and maintain steady levels of the medication in your system. If you typically eat breakfast, taking it with your morning meal often works well.

Your doctor will likely start you on a specific dosing schedule, often involving periods of taking the medication followed by brief breaks. This approach helps manage side effects while maintaining the drug's effectiveness.

How Long Should I Take Fruquintinib For?

You'll typically take fruquintinib for as long as it's helping control your cancer and you're tolerating it well. There's no predetermined end date for this type of targeted therapy.

Your doctor will monitor your response through regular scans and blood tests, usually every 6-8 weeks initially. These check-ups help determine if the medication is working and whether any dose adjustments are needed.

Some people take fruquintinib for months or even years, while others may need to stop sooner due to side effects or if the cancer begins growing again. Your treatment duration depends entirely on your individual response.

What Are the Side Effects of Fruquintinib?

Like all cancer medications, fruquintinib can cause side effects, though not everyone experiences them. Most side effects are manageable with proper care and monitoring from your healthcare team.

Here are the most common side effects you might experience:

• Hand-foot syndrome (redness, swelling, or pain on palms and soles)
• Diarrhea
• High blood pressure
• Fatigue
• Decreased appetite
• Nausea
• Voice changes or hoarseness

Your doctor will teach you how to manage these side effects and may prescribe supportive medications to help. Most people find that side effects become more manageable as their body adjusts to the treatment.

Some less common but more serious side effects can occur, and it's important to know when to contact your healthcare team:

• Severe bleeding or unusual bruising
• Signs of heart problems (chest pain, shortness of breath)
• Severe stomach pain
• Yellowing of skin or eyes
• Sudden severe headache
• Blood clots (leg swelling, chest pain)

These serious side effects are rare, but your medical team will monitor you closely with regular check-ups and blood tests to catch any issues early.

Who Should Not Take Fruquintinib?

Certain people should not take fruquintinib due to safety concerns. Your doctor will carefully review your medical history before prescribing this medication.

You should not take fruquintinib if you're pregnant or planning to become pregnant, as it can harm an unborn baby. Women of childbearing age need to use effective birth control during treatment and for several months after stopping.

People with certain heart conditions, uncontrolled high blood pressure, or recent major surgery may not be good candidates for this medication. Your doctor will also consider your liver and kidney function before prescribing fruquintinib.

If you're taking blood thinners or have a history of bleeding problems, your doctor will weigh the risks and benefits carefully before recommending this treatment.

Fruquintinib Brand Names

Fruquintinib is sold under the brand name Fruzaqla in the United States. In other countries, it may be available under different brand names or as a generic medication.

When picking up your prescription, make sure the pharmacy gives you the correct medication by checking both the generic name (fruquintinib) and brand name with your pharmacist.

Fruquintinib Alternatives

Several other targeted therapies work similarly to fruquintinib for colorectal cancer. These alternatives include regorafenib (Stivarga) and trifluridine/tipiracil (Lonsurf).

Your doctor might also consider other targeted therapies like bevacizumab (Avastin) or ramucirumab (Cyramza), depending on your specific cancer characteristics and previous treatments.

The choice between these medications depends on factors like your cancer's genetic makeup, previous treatments, side effect profile, and your overall health. Your oncologist will help determine which option offers the best balance of effectiveness and tolerability for your situation.

Is Fruquintinib Better Than Regorafenib?

Both fruquintinib and regorafenib are effective targeted therapies for advanced colorectal cancer, but they have different side effect profiles. Studies suggest fruquintinib may cause fewer severe side effects while providing similar cancer control benefits.

Fruquintinib tends to cause less hand-foot syndrome and fatigue compared to regorafenib, which may make it easier to tolerate for some patients. However, both medications can effectively slow tumor growth when used in the right situation.

Your doctor will consider your specific medical history, previous treatments, and current health status when choosing between these options. What works best varies from person to person.